Heart Attack Prevention
Reports on heart attack prevention findings from Hebei Medical University, Department of Cardiology provide new insights
Published in Drug Law Weekly, September 4th, 2007
Research findings, "Effect of intracoronary administration of anisodamine on slow reflow phenomenon following primary percutaneous coronary intervention in patients with acute myocardial infarction," are discussed in a new report. According to a study from Shijiazhuang, People's Republic of China, "Many basic and clinical studies have proved that anisodamine can produce significant effect on relieving microvascular spasm, improving and dredging the coronary microcirculation. It may be beneficial to the improvement of slow-reflow phenomenon (SRP) following percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI)."
"So we investigated the effect of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
Source: Drug Law Weekly (2007-09-04)
More Articles from Drug Law Weekly
- Allergies
Video: Food Allergies Mean Back-to-School Jitters for Millions of Students and Their Parents - Biopharmaceuticals
Expiry of Hart-Scott-Rodino waiting period for JUVISTA (human TGF3) - Biotech Business
Emisphere Technologies, Inc. Appoints Paul Lubetkin as Vice President and General Counsel - Drug Abuse
Leading Panamanian Hospital Centro Medico Paitilla to Serve as Hythiam's Initial PROMETA Licensee for Central and South America - Drug Development
Abigail Alliance Will Appeal D.C. Circuit Court Decision - Drug Development
Research from Stanford University has provided new information about drug development - More from this issue of Drug Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
